Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes

por Philis-Tsimikas, Athena
Publicado 2008

Periodic Intensive Insulin Therapy Remains Experimental

por Chang, Amy, Philis-Tsimikas, Athena
Publicado 2019

Digital health tools to promote diabetes education and management of cardiovascular risk factors among under-resourced populations

por Paul, Tenes, Mehawej, Jordy, Philis-Tsimikas, Athena
Publicado 2021

Predictors of glycemic control among patients with Type 2 diabetes: A longitudinal study

por Benoit, Stephen R, Fleming, Regina, Philis-Tsimikas, Athena, Ji, Ming
Publicado 2005

Predictors of Dropouts From a San Diego Diabetes Program: A Case Control Study

por Benoit, Stephen R., Ji, Ming, Fleming, Regina, Philis-Tsimikas, Athena
Publicado 2004

100 years on: the impact of the discovery of insulin on clinical outcomes

por Buse, John B, Davies, Melanie J, Frier, Brian M, Philis-Tsimikas, Athena
Publicado 2021

Improving Treatment of Depression Among Latinos With Diabetes Using Project Dulce and IMPACT

por Gilmer, Todd P., Walker, Chris, Johnson, Elizabeth D., Philis-Tsimikas, Athena, Unützer, Jürgen
Publicado 2008

Peer-Led Diabetes Education Programs in High-Risk Mexican Americans Improve Glycemic Control Compared With Standard Approaches: A Project Dulce promotora randomized trial

por Philis-Tsimikas, Athena, Fortmann, Adelaide, Lleva-Ocana, Leticia, Walker, Chris, Gallo, Linda C.
Publicado 2011

Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use)

por Philis-Tsimikas, Athena, Brod, Meryl, Niemeyer, Marcus, Ocampo Francisco, Ann Marie, Rothman, Jeffrey
Publicado 2013

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Rang...

por King, Allen B., Philis-Tsimikas, Athena, Kilpatrick, Eric S., Langbakke, Irene H., Begtrup, Kamilla, Vilsbøll, Tina
Publicado 2017

Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase‐4 inhibitors upon initiation of degludec/liraglutide t...

por Janez, Andrej, Őrsy, Petra, Stachlewska, Karolina, Salvesen‐Sykes, Karen, Billings, Liana K., Philis‐Tsimikas, Athena
Publicado 2020

The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL

por Philis‐Tsimikas, Athena, Lane, Wendy, Pedersen‐Bjergaard, Ulrik, Wysham, Carol, Bardtrum, Lars, Harring, Signe, Heller, Simon
Publicado 2020

Dulce Wireless Tijuana: A Randomized Control Trial Evaluating the Impact of Project Dulce and Short-Term Mobile Technology on Glycemic Control in a Family Medicine Clinic in Northe...

por Anzaldo-Campos, María Cecilia, Contreras, Sonia, Vargas-Ojeda, Adriana, Menchaca-Díaz, Rufino, Fortmann, Addie, Philis-Tsimikas, Athena
Publicado 2016

Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials

por Rose, Ludger, Kadowaki, Takashi, Pieber, Thomas R., Buchholtz, Kristine, Ekelund, Magnus, Gorst-Rasmussen, Anders, Philis-Tsimikas, Athena
Publicado 2019

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

por Zinman, Bernard, Philis-Tsimikas, Athena, Cariou, Bertrand, Handelsman, Yehuda, Rodbard, Helena W., Johansen, Thue, Endahl, Lars, Mathieu, Chantal
Publicado 2012

When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation

por Weatherall, James, Polonsky, William H., Lanar, Sally, Knoble, Naomi, Håkan-Bloch, Jonas, Constam, Elisabeth, Philis-Tsimikas, Athena, Marrel, Alexia
Publicado 2018

Glucose as the Fifth Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a Non-ICU Hospital Setting

por Fortmann, Addie L., Spierling Bagsic, Samantha R., Talavera, Laura, Garcia, Isabel Maria, Sandoval, Haley, Hottinger, Amiry, Philis-Tsimikas, Athena
Publicado 2020

Rationale and design of the phase 3a development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes

por Philis‐Tsimikas, Athena, Bajaj, Harpreet S., Begtrup, Kamilla, Cailleteau, Roman, Gowda, Amoolya, Lingvay, Ildiko, Mathieu, Chantal, Russell‐Jones, David, Rosenstock, Julio
Publicado 2022

Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial

por Mathieu, Chantal, Bode, Bruce W., Franek, Edward, Philis‐Tsimikas, Athena, Rose, Ludger, Graungaard, Tina, Birk Østerskov, Anne, Russell‐Jones, David
Publicado 2018

Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial

por Chaykin, Louis, Bhargava, Anuj, de la Rosa, Raymond, Wysham, Carol H., Nørgård Troelsen, Lone, Østoft, Signe H., Philis-Tsimikas, Athena
Publicado 2019